Mesenchymal stem cells in the treatment of spinal cord injuries: A review.

Abstract

With technological advances in basic research, the intricate mechanism of secondary delayed spinal cord injury (SCI) continues to unravel at a rapid pace. However, despite our deeper understanding of the molecular changes occurring after initial insult to the spinal cord, the cure for paralysis remains elusive. Current treatment of SCI is limited to early administration of high dose steroids to mitigate the harmful effect of cord edema that occurs after SCI and to reduce the cascade of secondary delayed SCI. Recent evident-based clinical studies have cast doubt on the clinical benefit of steroids in SCI and intense focus on stem cell-based therapy has yielded some encouraging results. An array of mesenchymal stem cells (MSCs) from various sources with novel and promising strategies are being developed to improve function after SCI. In this review, we briefly discuss the pathophysiology of spinal cord injuries and characteristics and the potential sources of MSCs that can be used in the treatment of SCI. We will discuss the progress of MSCs application in research, focusing on the neuroprotective properties of MSCs. Finally, we will discuss the results from preclinical and clinical trials involving stem cell-based therapy in SCI.

• Authors: Venkata Ramesh Dasari, Krishna Kumar Veeravalli, Dzung H Dinh
• Journal: World journal of stem cells (World J Stem Cells) Vol. 6 Issue 2 Pg. 120-33 (Apr 26 2014) ISSN: 1948-0210 [Print] United States
• PMID: 24772239 (Publication Type: Journal Article, Review)